NIH Notices

  • Updated Appendix Policy Eliminates Clinical Trial-Related Materials for NIH/AHRQ/NIOSH Applications Submitted to Due Dates on or After January 25, 2018
    (NOT-OD-17-098) National Institutes of Health
  • Notice of Intent to Renew a Funding Opportunity Announcement for Autoimmunity Centers of Excellence (ACE) Clinical Research Program (UM1)
    (NOT-AI-17-033)
    National Institute of Allergy and Infectious Diseases
  • Notice of Correction in Expiration Date for PAR-17-331 “Discovery of Small Molecule Immunomodulators for Cancer Therapy (R01)”
    (NOT-CA-17-075)
    National Cancer Institute
  • Notice of Correction in Expiration Date for PA-17-330 “Using Small Molecules and Molecular Genetics to Identify Novel Targets and Mechanisms Contributing to Tumor Immune Evasion (R01)”
    (NOT-CA-17-076)
    National Cancer Institute
  • Notice of Correction in Expiration Date for PAR-17-438 “Assay development and screening for discovery of chemical probes or therapeutic agents (R01)”
    (NOT-CA-17-077)
    National Cancer Institute
  • Notice of Change to Key Dates, PAR-17-242 “Extracellular Vesicles and Substance Use Disorders (R21)”
    (NOT-DA-17-050)
    National Institute on Drug Abuse
  • Notice of Change to Key Dates, PAR-17-250 “Extracellular Vesicles and Substance Use Disorders (R01)”
    (NOT-DA-17-051)
    National Institute on Drug Abuse
  • Notice of Change to Expiration Date and Award Information in PAR-17-334 “Synthetic Biology for Engineering Applications (R01)”
    (NOT-EB-17-007)
    National Institute of Biomedical Imaging and Bioengineering
  • Notice of Withdrawal from participation in PA-16-161 “NIH Exploratory/Developmental Research Grant Program (Parent R21)”
    (NOT-EB-17-008)
    National Institute of Biomedical Imaging and Bioengineering
  • Notice of Withdrawal from participation in PA-16-040 “Exploratory/Developmental Bioengineering Research Grants (EBRG)(R21)”
    (NOT-EB-17-009)
    National Institute of Biomedical Imaging and Bioengineering
  • Notice of Intent to Publish a Funding Opportunity Announcement for Contraception Research Centers Program (U54)
    (NOT-HD-17-016)
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
  • NICHD Policy on Receipt of Investigator-Initiated Clinical Trials
    (NOT-HD-17-019)
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
  • Notice of NICHD Participation in PAR-17-083 “NIBIB Biomedical Technology Resource Centers (P41)”
    (NOT-HD-17-020)
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
  • Notice of Replacement of Funding Opportunity Announcements for NHGRI’s Ethical, Legal, and Social Implications of Genomic Research PA-17-323, PA-17-324 and PA-17-325
    (NOT-HG-17-012)
    National Human Genome Research Institute
  • Notice of Information Regarding NOT-HL-17-490 “New Epidemiology Cohort Studies in Heart, Lung, Blood, and Sleep Diseases and Disorders (U01)”
    (NOT-HL-17-530)
    National Heart, Lung, and Blood Institute

Updates for PAR-16-098 “Cooperative Research Agreements Related to World Trade Center Health Program (U01)”
(NOT-OH-17-011)
National Institute for Occupational Safety and Health

Advertisements
This entry was posted in Uncategorized. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s